Aikido pharma announces phase 1 data to be presented at the american society of clinical oncology ("asco") annual meeting

New york, may 20, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced that phase 1 testing data will be presented at the 2021 asco annual meeting june 4, 2021.  the presentation of the data will be by dr. scott tagawa, a professor of medicine & urology at weill cornell medicine and an aikido pharma scientific advisory board member.
DOMH Ratings Summary
DOMH Quant Ranking